Lista de obras -

A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3

scientific journal article

A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer: final results

artículo científico publicado en 2012

A randomized controlled trial of celecoxib to prevent recurrence of nonmuscle-invasive bladder cancer

artículo científico publicado en 2011

Ability of clinical grade to predict final pathologic stage in upper urinary tract transitional cell carcinoma: implications for therapy

artículo científico publicado en 2007

Association of polymorphisms in oxidative stress genes with clinical outcomes for bladder cancer treated with Bacillus Calmette-Guérin

artículo científico publicado en 2012

Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes.

artículo científico publicado en 2006

Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers

artículo científico publicado en 2005

Concepts for banking tissue in urologic oncology--the International Bladder Cancer Bank.

artículo científico publicado en 2005

Considerations on the use of urine markers in the management of patients with high-grade non-muscle-invasive bladder cancer.

artículo científico publicado en 2014

Considerations on the use of urine markers in the management of patients with low-/intermediate-risk non-muscle invasive bladder cancer

artículo científico

Do mixed histological features affect survival benefit from neoadjuvant platinum‐based combination chemotherapy in patients with locally advanced bladder cancer? A secondary analysis of Southwest Oncology Group‐Directed Intergroup Study (S8710) ⬇️

artículo científico publicado el 24 de noviembre de 2010

Effects of mTOR Inhibitor Everolimus (RAD001) on Bladder Cancer Cells ⬇️

artículo científico publicado el 17 de marzo de 2011

Energy balance, the PI3K-AKT-mTOR pathway genes, and the risk of bladder cancer

artículo científico publicado en 2010

Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M. D. Anderson cancer experience.

artículo científico publicado en 2004

Focus on bladder cancer

artículo científico publicado en 2004

Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer

artículo científico publicado en 2009

Genetic variations in the sonic hedgehog pathway affect clinical outcomes in non-muscle-invasive bladder cancer

artículo científico publicado en 2010

Genetic variations of the PI3K-AKT-mTOR pathway and clinical outcome in muscle invasive and metastatic bladder cancer patients

artículo científico publicado en 2010

Genome-wide association study identifies multiple loci associated with bladder cancer risk

artículo científico publicado en 2014

Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer

artículo científico publicado en 2010

If cystectomy is insufficient, what is an urologist to do?

artículo científico publicado en 2003

Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33

artículo científico publicado en 2014

Innovation in Bladder Cancer Immunotherapy

artículo científico publicado en 2016

Intake of red meat and heterocyclic amines, metabolic pathway genes and bladder cancer risk ⬇️

artículo científico publicado el 6 de marzo de 2012

Long-Term Decrease in Bladder Cancer Recurrence with Hexaminolevulinate Enabled Fluorescence Cystoscopy ⬇️

artículo científico publicado el 12 de mayo de 2012

Loss of 15-hydroxyprostaglandin dehydrogenase expression contributes to bladder cancer progression

artículo científico publicado en 2010

Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC.

artículo científico publicado en 2008

Malignant mesothelioma of the tunica vaginalis

artículo científico publicado en 2005

Microhematuria assessment an IBCN consensus-Based upon a critical review of current guidelines

artículo científico publicado en 2016

Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients

artículo científico publicado en 2007

Neoadjuvant chemotherapy for bladder cancer

artículo científico publicado en 2003

Neoadjuvant chemotherapy in small cell urothelial cancer improves pathologic downstaging and long-term outcomes: results from a retrospective study at the MD Anderson Cancer Center.

artículo científico publicado en 2012

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer

artículo científico publicado en 2003

Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer.

artículo científico publicado en 2005

Outcome and patterns of recurrence of nonbilharzial pure squamous cell carcinoma of the bladder: a contemporary review of The University of Texas M D Anderson Cancer Center experience

artículo científico publicado en 2007

Outcome of patients with bladder cancer with pN+ disease after preoperative chemotherapy and radical cystectomy.

artículo científico publicado en 2008

P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors

artículo científico publicado en 2007

Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience

artículo científico publicado en 2006

Perioperative Outcomes of Laparoscopic Radical Nephroureterectomy and Regional Lymphadenectomy in Patients With Upper Urinary Tract Urothelial Carcinoma After Neoadjuvant Chemotherapy ⬇️

artículo científico publicado el 26 de febrero de 2011

Phase II clinical trial of neoadjuvant alternating doublet chemotherapy with ifosfamide/doxorubicin and etoposide/cisplatin in small-cell urothelial cancer

artículo científico publicado en 2009

Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data

artículo científico publicado en 2013

Proceedings of the 3rd Annual Albert Institute for Bladder Cancer Research Symposium.

artículo científico publicado en 2017

Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers

artículo científico publicado en 2005

Quality of pathologic response and surgery correlate with survival for patients with completely resected bladder cancer after neoadjuvant chemotherapy

artículo científico publicado en 2009

Recent developments in the treatment of bladder cancer.

artículo científico publicado en 2003

Refining patient selection for neoadjuvant chemotherapy before radical cystectomy

artículo científico publicado en 2013

Roles of tumor suppressor and telomere maintenance genes in cancer and aging--an epidemiological study

artículo científico publicado en 2005

Safety of hexaminolevulinate for blue light cystoscopy in bladder cancer. A combined analysis of the trials used for registration and postmarketing data

artículo científico publicado en 2014

Selective COX-2 inhibitors as chemopreventive and therapeutic agents.

artículo científico publicado en 2003

The 19q12 bladder cancer GWAS signal: association with cyclin E function and aggressive disease

artículo científico publicado en 2014

The International Bladder Cancer Bank: proposal for a new study concept

artículo científico publicado en 2004

The International Bladder Cancer Network

artículo científico publicado en 2010

The role of radical cystectomy in patients with clinical T4b bladder cancer

artículo científico publicado en 2010

Tumor suppressor genes of bladder cancer and potential for gene therapy.

artículo científico publicado en 2003

Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategy

artículo científico publicado en 2008

Use of Fluorescence In Situ Hybridization to Predict Response to Bacillus Calmette-Guérin Therapy for Bladder Cancer: Results of a Prospective Trial ⬇️

artículo científico publicado el 15 de enero de 2012

Lista de obras de

A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3

A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer: final results

A randomized controlled trial of celecoxib to prevent recurrence of nonmuscle-invasive bladder cancer

Ability of clinical grade to predict final pathologic stage in upper urinary tract transitional cell carcinoma: implications for therapy

Association of polymorphisms in oxidative stress genes with clinical outcomes for bladder cancer treated with Bacillus Calmette-Guérin

Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes.

Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers

Concepts for banking tissue in urologic oncology--the International Bladder Cancer Bank.

Considerations on the use of urine markers in the management of patients with high-grade non-muscle-invasive bladder cancer.

Considerations on the use of urine markers in the management of patients with low-/intermediate-risk non-muscle invasive bladder cancer

Do mixed histological features affect survival benefit from neoadjuvant platinum‐based combination chemotherapy in patients with locally advanced bladder cancer? A secondary analysis of Southwest Oncology Group‐Directed Intergroup Study (S8710) ⬇️

Effects of mTOR Inhibitor Everolimus (RAD001) on Bladder Cancer Cells ⬇️

Energy balance, the PI3K-AKT-mTOR pathway genes, and the risk of bladder cancer

Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M. D. Anderson cancer experience.

Focus on bladder cancer

Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer

Genetic variations in the sonic hedgehog pathway affect clinical outcomes in non-muscle-invasive bladder cancer

Genetic variations of the PI3K-AKT-mTOR pathway and clinical outcome in muscle invasive and metastatic bladder cancer patients

Genome-wide association study identifies multiple loci associated with bladder cancer risk

Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer

If cystectomy is insufficient, what is an urologist to do?

Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33

Innovation in Bladder Cancer Immunotherapy

Intake of red meat and heterocyclic amines, metabolic pathway genes and bladder cancer risk ⬇️

Long-Term Decrease in Bladder Cancer Recurrence with Hexaminolevulinate Enabled Fluorescence Cystoscopy ⬇️

Loss of 15-hydroxyprostaglandin dehydrogenase expression contributes to bladder cancer progression

Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC.

Malignant mesothelioma of the tunica vaginalis

Microhematuria assessment an IBCN consensus-Based upon a critical review of current guidelines

Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients

Neoadjuvant chemotherapy for bladder cancer

Neoadjuvant chemotherapy in small cell urothelial cancer improves pathologic downstaging and long-term outcomes: results from a retrospective study at the MD Anderson Cancer Center.

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer

Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer.

Outcome and patterns of recurrence of nonbilharzial pure squamous cell carcinoma of the bladder: a contemporary review of The University of Texas M D Anderson Cancer Center experience

Outcome of patients with bladder cancer with pN+ disease after preoperative chemotherapy and radical cystectomy.

P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors

Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience

Perioperative Outcomes of Laparoscopic Radical Nephroureterectomy and Regional Lymphadenectomy in Patients With Upper Urinary Tract Urothelial Carcinoma After Neoadjuvant Chemotherapy ⬇️

Phase II clinical trial of neoadjuvant alternating doublet chemotherapy with ifosfamide/doxorubicin and etoposide/cisplatin in small-cell urothelial cancer

Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data

Proceedings of the 3rd Annual Albert Institute for Bladder Cancer Research Symposium.

Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers

Quality of pathologic response and surgery correlate with survival for patients with completely resected bladder cancer after neoadjuvant chemotherapy

Recent developments in the treatment of bladder cancer.

Refining patient selection for neoadjuvant chemotherapy before radical cystectomy

Roles of tumor suppressor and telomere maintenance genes in cancer and aging--an epidemiological study

Safety of hexaminolevulinate for blue light cystoscopy in bladder cancer. A combined analysis of the trials used for registration and postmarketing data

Selective COX-2 inhibitors as chemopreventive and therapeutic agents.

The 19q12 bladder cancer GWAS signal: association with cyclin E function and aggressive disease

The International Bladder Cancer Bank: proposal for a new study concept

The International Bladder Cancer Network

The role of radical cystectomy in patients with clinical T4b bladder cancer

Tumor suppressor genes of bladder cancer and potential for gene therapy.

Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategy

Use of Fluorescence In Situ Hybridization to Predict Response to Bacillus Calmette-Guérin Therapy for Bladder Cancer: Results of a Prospective Trial ⬇️